Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
23.04.25
/
50%
€103.95
Target price
23.04.26
€172.63
Performance (%)
53.54%
Price
13:58
€159.60
Summary
This prediction is currently active. With a performance of 53.54% the BUY prediction by The_Goldman_Sachs_Gr is a big success. This prediction currently runs until 23.04.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.924% | -0.924% |
| iShares Core DAX® | -0.437% | -5.315% |
| iShares Nasdaq 100 | -0.194% | 3.078% |
| iShares Nikkei 225® | -0.951% | -5.884% |
| iShares S&P 500 | -0.420% | 0.922% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $219.00 to $197.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat